Report Overview

Global Digital Pathology Market size- Industry Trends & Forecast Report 2026

Global Digital Pathology Market Forecast and Trends

The global market of Digital Pathology Market has reached USD 0.52 Billion in 2019 and projected to reach USD 1.06 Billion by 2026 with a significant CAGR of 12.6% during the forecast period 2020-2026. The cost-efficiency of digital pathology products, easy virtual transportation of slides, and high effectiveness of digital pathology systems are the key factors that drive the growth of the global digital pathology market.

Increasing initiatives toward the commercialization of cost-efficient digital pathology systems is expected to provide profitable growth opportunities for service providers over the forecast period. Advanced imaging and diagnostic alternatives are opted owing to, high prevalence of cardiovascular diseases. The rising dominance of chronic conditions is expected to surge clinical urgency to adopt digital pathology to enhance existing poor patient diagnostic imaging measures and to decrease high costs related to conventional diagnostics.

Source: BlueWeave Consulting

Global Digital Pathology Market: Overview

Digital pathology is an image-based information setting facilitated by computer technology that enables the management of information produced through a digital slide. The digitalization of pathology has led to the automation of tests during disease diagnosis among other applications. For example, a single digital instrument can perform tests that were previously carried out using five instruments by pathologists. Digital pathology solutions provide high-resolution sample scanning, scrutiny & analysis of images on a computer, and online storage of digital slides, which allows pathologists to cross-examine slides without physical evidence.

Growth Drivers

Rising prevalence of Cancer offers market opportunities

The increasing prevalence of cancer has led to a rising need for faster and more accurate methods of subtyping diseases. Digital pathology systems provide an accurate diagnosis and secure exchange of data among pathologists that improve the diagnostic quality. Growing spending on cancer diagnostics and healthcare IT spending structure modifications has caused the extensive popularity of digital pathology systems among research centers, hospitals, and diagnostic laboratories. The rising number of hospitals and diagnostics laboratories is a factor also expected to boost overall demand for digital pathology systems globally. Increasing cancer incidences and rising demand for collaborative second opinion technology by patients is leading to the overall growth of the digital pathology market globally.

Technological advancements to discover new applications contributes to the market growth

The technological advancements have led the efforts towards the integration of a laboratory information system with a digital pathology system, which is expected to create numerous opportunities for the players operating in the digital pathology market. Vendors in the digital pathology market are continuously focusing on developments to discover new applications in drug discovery, clinical testing, and diagnosis. Digital pathology has also adopted by the education sector in various graduate and undergraduate programs. Apart from improved learning, the adoption of digital pathology also provides benefits such as improved accessibility to pathology information and the standardization of study materials. Resulting, there is a substantial increase in the adoption of digital pathology in the education and training sector. For the improvement and development of pathologic assessments, educational institutions are also emphasizing on forming partnerships with market vendors.

Restraint

High cost and lack of well-established internet infrastructure

A lack of well-established internet infrastructure, specifically in emerging countries, expensive nature of digital pathology solutions, and lack of reimbursement combined with high installation and maintenance cost of the digital pathology systems, is projected to obstruct the growth of the digital pathology market. However, the dearth of skilled personnel, unclear reimbursement policies, and the unwillingness of older pathologists to opt for new technology restrict the digital pathology market growth.

Global Digital Pathology Market: Product

On the basis of its product, the market is segregated into Software, Device, Communication Systems, Storage Systems. The device segment is anticipated to dominate the digital pathology market in terms of revenue share during the forecast period. The devices include scanner and slide management systems. Rising academic research activities and improved resolution are the major growth drivers. This technology is projected to witness lucrative growth over the forecast period due to advancements in magnification and scanning of slides at the Z-axis, which is provided by whole slide imaging.

Global Digital Pathology Market: Type

Based on type, the market is bifurcated into Human Pathology, Veterinary Pathology. The human pathology type is estimated to account for the larger share of the digital pathology market owing to the rising burden of chronic diseases, such as cancer, hepatitis A, and hepatitis B. Critical monitoring is needed during the treatment of these diseases, which is possible due to the accurate consultations offered by digital pathology services.

Global Digital Pathology Market: Application

Based on application the market is classified into Teleconsultation, Disease Diagnosis, Drug Discovery, Training and Education, and Others. The academic research segment is expected to dominate the market due to varied applications of the systems in several research procedures such as biomarker profiling and tumor morphological study. Moreover, the focus of the manufacturers on the development of innovative and rapid diagnostic techniques is expected to showcase lucrative growth of this segment.

Global Digital Pathology Market: End-User

On the basis of its end-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, Academic & Research Institutes. Pharmaceuticals & Biotechnology companies segment is estimated to exhibit steady growth during the forecast period. The growth is accredited to the growing usage of digital pathology in oncology clinical trials, drug development, and preclinical GLP pathology. Rising prevalence of cancer and demand for enhanced treatment options is expected to further fuel the segment over the forecast period.

Global Digital Pathology Market: Regional Insights

On the basis of regional analysis, the global digital pathology market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America is expected to be the largest market for digital pathology. The growing adoption of advanced pathology practices and the existence of a large number of vendors are fueling market growth in the region. Constant deployment of R&D investments, supportive government initiatives relating to rising adoption of digital imaging, the development of technologically advanced systems, and the presence of major players are the major contributing factors.

Competitive Landscape

The digital Pathology market is fragmented owing to the presence of number of large-sized companies, mid-sized & small-sized companies, and many start-ups that provide Digital Pathology industry. However, the companies that hold the majority share of Digital Pathology market are Leica Biosystems, Ventana Medical Systems, Hamamatsu Photonics, 3DHISTECH, Koninklijke Philips, Roche, Apollo Enterprise Imaging, XIFIN, Huron Digital Pathology, Visiopharm, Corista, Indica Labs, Objective Pathology Services, Olympus Corporation, Mikroscan Technologies, Digipath, Inc., TRIBVN Healthcare, Danaher, Nikon Corporation, and other prominent players.

Recent Development

Ø  In January 2019, Roche launched its new enterprise software for digital pathology, uPath. uPath software offers facility to examine high-resolution images along with patient conditions within one view.

Ø  In October 2018, TRIBVN Healthcare, a strong player in the digital pathology market, announced the launch of CaloPix 4.0.0., an advanced software solution for digital pathology with extensive configuration to provide image analysis and management.

Scope of the Report

By Product

Ø  Software

Ø  Device

Ø  Communication Systems

Ø  Storage Systems

By Type

Ø  Human Pathology

Ø  Veterinary Pathology

By Application

Ø  Teleconsultation

Ø  Disease Diagnosis

Ø  Drug Discovery

Ø  Training and Education

Ø  Others

By End-User

Ø  Pharmaceutical & Biotechnology Companies

Ø  Hospitals and Reference Laboratories

Ø  Academic & Research Institutes

By Region:  

Ø  North America

Ø  Europe

Ø  Asia Pacific

Ø  Latin America

Ø  Middle East & Africa

The objective of the Study:

Ø  To analyze and forecast the global Digital Pathology Market size of the market in terms of value.

Ø  To examine the careful market segmentation and forecast the market size, in terms of value, based on the region by segmenting.

Ø  The Global Digital Pathology Market segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America and Middle East & Africa coupled with their leading countries.

Ø  To outline, categorized, and forecast the global Digital Pathology Market based on the Product, Type, Application, and End-User coupled with the region.

Ø  To examine competitive developments like technological advancement, services, and regulative framework within the global Digital Pathology Market.

Ø  To highlight the impact analysis of the factors affecting the market dynamics such as drivers, restraints, opportunities, and challenges.

Ø  To strategically profile the key players and comprehensively analyze their market shares along with detailing the competitive landscape for market leaders.

SCOPE  

1.      Research Framework

1.1.    Research Objective

1.2.    Product Overview

1.3.    Market Segmentation

2.       Research Methodology

2.1.    Qualitative Research

2.1.1.Primary & Secondary Sources

2.2.    Quantitative Research

2.2.1.Primary & Secondary Sources

2.3.    Breakdown of Primary Research Respondents, By Region

2.3.1.Secondary Research

2.3.2.Primary Research

2.4.    Breakdown of Primary Research Respondents

2.5.    Market Size Estimation

2.6.    Assumption For The Study

2.7.    Market Breakdown & Data Triangulation

3.       Executive Summary

4.       Global Digital Pathology Insights

4.1.    DROC Analysis

4.1.1.Growth Drivers

4.1.2.Restraints

4.1.3.Opportunities

4.1.4.Challenges

4.2.    Technological Landscape/Recent Developments

4.3.    Regulatory Framework

4.4.    Company Market Share Analysis,2019

4.5.    Porter’s Five Forces Analysis

4.5.1.Bargaining Power of Suppliers

4.5.2.Bargaining Power of Buyers

4.5.3.Threat of New Entrants

4.5.4.Threat of Substitutes

4.5.5.Intensity of Rivalry

5.       Global Digital Pathology Market Overview

5.1.    Market Size & Forecast By Value, 2016-2026

5.1.1.By Value (USD Billion)

5.2.    Market Share & Forecast

5.2.1.       By Product

5.2.1.1.              Software

5.2.1.2.              Device

5.2.1.3.              Communication Systems

5.2.1.4.              Storage Systems

5.2.2.       By Type

5.2.2.1.              Human Pathology

5.2.2.2.              Veterinary Pathology

5.2.3.       By Application

5.2.3.1.              Teleconsultation

5.2.3.2.              Disease Diagnosis

5.2.3.3.              Drug Discovery

5.2.3.4.              Training and Education

5.2.3.5.              Others

5.2.4.       By End-User

5.2.4.1.              Pharmaceutical & Biotechnology Companies

5.2.4.2.              Hospitals and Reference Laboratories

5.2.4.3.              Academic & Research Institutes

5.2.5.       By Region

5.2.5.1.              North America

5.2.5.2.              Europe

5.2.5.3.              Asia Pacific

5.2.5.4.              Latin America

5.2.5.5.              Middle East & Africa

6.       North America Digital Pathology Market

6.1.    Market Size & Forecast By Value, 2016-2026

6.1.1.By Value (USD Billion)

6.2.    Market Share & Forecast

6.2.1.By Product

6.2.2.By Type

6.2.3.By Application

6.2.4.By End-User

6.2.5.By Country

6.2.5.1.              United States

6.2.5.2.              Canada

7.       Europe Digital Pathology Market

7.1.    Market Size & Forecast By Value, 2016-2026

7.1.1.By Value (USD Billion)

7.2.    Market Share & Forecast

7.2.1.By Product

7.2.2.By Type

7.2.3.By Application

7.2.4.By End-User

7.2.5.By Country

7.2.5.1.              Germany

7.2.5.2.              United Kingdom

7.2.5.3.              France

7.2.5.4.              Italy

7.2.5.5.              Spain

7.2.5.6.              Rest of Europe

8.       Asia Pacific Digital Pathology Market

8.1.    Market Size & Forecast By Value, 2016-2026

8.1.1.By Value (USD Billion)

8.2.    Market Share & Forecast

8.2.1.By Product

8.2.2.By Type

8.2.3.By Application

8.2.4.By End-User

8.2.5.By Country

8.2.5.1.              China

8.2.5.2.              India

8.2.5.3.              Japan

8.2.5.4.              South Korea

8.2.5.5.              Rest of Asia Pacific

9.       Latin America Digital Pathology Market

9.1.    Market Size & Forecast By Value, 2016-2026

9.1.1.By Value (USD Billion)

9.2.    Market Share & Forecast

9.2.1.By Product

9.2.2.By Type

9.2.3.By Application

9.2.4.By End-User

9.2.5.By Country

9.2.5.1.              Brazil

9.2.5.2.              Mexico

9.2.5.3.              Argentina

9.2.5.4.              Rest of Latin America

10.   Middle East & Africa Digital Pathology Market

10.1.  Market Size & Forecast By Value, 2016-2026

10.1.1.    By Value (USD Billion)

10.2.  Market Share & Forecast

10.2.1.    By Product

10.2.2.    By Type

10.2.3.    By Application

10.2.4.    By End-User

10.2.5.    By Country

10.2.5.1.    Saudi Arabia

10.2.5.2.    UAE

10.2.5.3.    South Africa

10.2.5.4.    Rest of Middle East and Africa

11.   Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, and Contact Address)*

11.1.  Leica Biosystems

11.2.  Ventana Medical Systems

11.3.  Hamamatsu Photonics

11.4.  3DHISTECH

11.5.  Koninklijke Philips

11.6.  Roche

11.7.  Apollo Enterprise Imaging

11.8.  XIFIN

11.9.  Huron Digital Pathology

11.10.   Visiopharm

11.11.   Corista

11.12.   Indica Labs

11.13.   Objective Pathology Services

11.14.   Olympus Corporation

11.15.   Mikroscan Technologies

11.16.   Digipath, Inc.

11.17.   TRIBVN Healthcare

11.18.   Danaher

11.19.   Nikon Corporation

11.20.   Other Prominent Players

*Financial Details will be captured as per data availability in case of unlisted companies.

**The user segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable.